IRONWOOD PHARMACEUTICALS INC (IRWD) › Operating IncomeIRONWOOD PHARMACEUTICALS INC (IRWD) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$60.82M2010: -$60.77M2011: -$66.14M2012: -$72.76M2013: -$252.00M2014: -$169.37M2015: -$102.09M2016: -$51.87M2017: -$15.36M2018: -$150.67M2019: $120.12M2020: $142.94M2021: $232.26M2022: $250.34M2023: -$945.43M2024: $93.12M2025: $98.50M$98.50M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$98.50M+5.8%2024$93.12M+109.8%2023-$945.43M-477.7%2022$250.34M+7.8%2021$232.26M+62.5%2020$142.94M+19.0%2019$120.12M+179.7%2018-$150.67M-880.7%2017-$15.36M+70.4%2016-$51.87M+49.2%2015-$102.09M+39.7%2014-$169.37M+32.8%2013-$252.00M-246.3%2012-$72.76M-10.0%2011-$66.14M-8.8%2010-$60.77M+0.1%2009-$60.82M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share